Skip to main content
Top
Published in: Indian Journal of Gastroenterology 3/2011

01-05-2011 | Original Article

Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in Northern India

Authors: Praveen Kumar Sharma, Vineet Ahuja, Kaushal Madan, Saurabh Gupta, Akshay Raizada, Mahesh Prakash Sharma

Published in: Indian Journal of Gastroenterology | Issue 3/2011

Login to get access

Abstract

Background and aims

Gastroesophageal reflux disease (GERD) is considered to be a common and chronic gastrointestinal disorder. The prevalence of GERD is believed to be less in Asia than in Western countries. Population-based data on GERD are lacking from India. The present study aimed at determining the prevalence of GERD symptoms in an adult Indian community and the potential risk factors associated with GERD.

Methods

The study population consisted of all the employees of All India Institute of Medical Sciences, New Delhi. An interview-based observational study was done on the basis of an earlier validated questionnaire. The subjects were asked about the frequency and severity of heartburn and/or regurgitation experienced by them in the previous year. These symptoms were then scored from 0 to 18. Subjects with a score of at least 4 were considered to have symptomatic GERD. Association of GERD with factors like age, sex, BMI, Kuppuswamy social class index, smoking, alcohol, NSAID use, and comorbid illness was analyzed.

Results

A total of 4079 employees were interviewed in person on a 29-item questionnaire from June 2003 to January 2005. Of the 4039 eligible subjects, 653 (16.2%) had GERD; 3.6% had heartburn on daily basis and 5.9% on a weekly basis. The corresponding prevalences for regurgitation were 3.3% and 5.0%, respectively. One hundred and eight of 4039 (2.7%) had severe GERD symptoms. Higher BMI (OR = 1.90, 95% CI: 1.4–2.6 for BMI ≥ 25), current smoking (OR = 1.48, 95% CI: 1.19–1.83), asthma (OR = 3.13, CI: 2.06–4.76) and hypertension (OR = 1.71, 95% CI: 1.16–2.50) were associated with the presence of GERD symptoms.

Conclusions

Prevalence of GERD in an urban adult population from northern India is 16.2% which is similar to other industrialized countries. Higher body mass index, current smoking, and presence of asthma or hypertension predisposes to GERD in our population.
Literature
1.
go back to reference Locke 3rd GR, Talley NJ, Fett SL, Zinsmister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead County, Minnesota. Gastroenterology. 1997;112:1448–56.PubMedCrossRef Locke 3rd GR, Talley NJ, Fett SL, Zinsmister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead County, Minnesota. Gastroenterology. 1997;112:1448–56.PubMedCrossRef
2.
go back to reference Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-esophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003;17:1309–17.PubMedCrossRef Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-esophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003;17:1309–17.PubMedCrossRef
3.
go back to reference Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-esophageal reflux disease in an adult population. Ann Med. 1995;27:67–70.PubMedCrossRef Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-esophageal reflux disease in an adult population. Ann Med. 1995;27:67–70.PubMedCrossRef
4.
go back to reference Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population based study. N Z Med J. 2000;113:178–81.PubMed Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population based study. N Z Med J. 2000;113:178–81.PubMed
5.
go back to reference Diaz-Rubio M, Moreno-elola-olaso C, Rey E, Locke III GR, Rodrigues-Artalejo F. Symptoms of gastro-esophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther. 2004;19:95–105.PubMedCrossRef Diaz-Rubio M, Moreno-elola-olaso C, Rey E, Locke III GR, Rodrigues-Artalejo F. Symptoms of gastro-esophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther. 2004;19:95–105.PubMedCrossRef
6.
go back to reference Goh KL, Chang SC, Fock KM, Ke MY, Park NJ, Lam JK. Gastro-oesopharyngeal reflux disease in Asia. J Gastroenterol Hepatol. 2000;15:230–8.PubMedCrossRef Goh KL, Chang SC, Fock KM, Ke MY, Park NJ, Lam JK. Gastro-oesopharyngeal reflux disease in Asia. J Gastroenterol Hepatol. 2000;15:230–8.PubMedCrossRef
7.
go back to reference Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16:495–501.PubMedCrossRef Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16:495–501.PubMedCrossRef
8.
go back to reference Wong WM, Lai KC, Lam LF, et al. Prevalence, clinical spectrum and health care utilisation of gastro-oesophageal reflux disease in a Chinese population: a population based study. Aliment Pharmacol Ther. 2003;18:595–604.PubMedCrossRef Wong WM, Lai KC, Lam LF, et al. Prevalence, clinical spectrum and health care utilisation of gastro-oesophageal reflux disease in a Chinese population: a population based study. Aliment Pharmacol Ther. 2003;18:595–604.PubMedCrossRef
9.
go back to reference Goh KL. Changing epidemiology of gastro-oesophageal reflux disease in the Asia-Pacific region: an overview. J Gastroenterol Hepatol. 2004;19:S22–5.PubMedCrossRef Goh KL. Changing epidemiology of gastro-oesophageal reflux disease in the Asia-Pacific region: an overview. J Gastroenterol Hepatol. 2004;19:S22–5.PubMedCrossRef
10.
go back to reference Ho KY, Lim LS, Goh WT, Lee JMJ. The prevalence of gastro-oesophageal reflux has increased in Asia: a longitudinal study in the community. J Gastroenterol Hepatol. 2002;16:A132. Ho KY, Lim LS, Goh WT, Lee JMJ. The prevalence of gastro-oesophageal reflux has increased in Asia: a longitudinal study in the community. J Gastroenterol Hepatol. 2002;16:A132.
11.
go back to reference Chitturi S, Farrel GC, George J. Non-alcoholic steatohepatitis in the Asia-pacific region: future shock. J Gastroenterol Hepatol. 2004;19:368–74.PubMedCrossRef Chitturi S, Farrel GC, George J. Non-alcoholic steatohepatitis in the Asia-pacific region: future shock. J Gastroenterol Hepatol. 2004;19:368–74.PubMedCrossRef
12.
go back to reference Klauser AG, Schindlebect NE, Muller-Lissner A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–8.PubMedCrossRef Klauser AG, Schindlebect NE, Muller-Lissner A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–8.PubMedCrossRef
13.
go back to reference Locke III GR, Talley NJ, Fett SL, Zinsmeister AR, Mellton LJ. Risk factors associated with symptoms of gastro-oesophageal reflux. Am J Med. 1999;106:642–9.PubMedCrossRef Locke III GR, Talley NJ, Fett SL, Zinsmeister AR, Mellton LJ. Risk factors associated with symptoms of gastro-oesophageal reflux. Am J Med. 1999;106:642–9.PubMedCrossRef
14.
go back to reference Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic/international gastroenterology surveillance study (DIGEST). Scand J Gastroenterol. 1999;231 Suppl:20–8.CrossRef Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic/international gastroenterology surveillance study (DIGEST). Scand J Gastroenterol. 1999;231 Suppl:20–8.CrossRef
15.
go back to reference Mishra D, Singh HP. Kuppuswamy’s socioeconomic scale—a revision. Indian J Pediatr. 2003;70:273–4.PubMedCrossRef Mishra D, Singh HP. Kuppuswamy’s socioeconomic scale—a revision. Indian J Pediatr. 2003;70:273–4.PubMedCrossRef
16.
go back to reference Madan K, Ahuja V, Gupta SD, et al. Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard. J Gasteroenterol Hepatol. 2005;20:30–7.CrossRef Madan K, Ahuja V, Gupta SD, et al. Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard. J Gasteroenterol Hepatol. 2005;20:30–7.CrossRef
17.
go back to reference Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Eng J Med. 1995;333:1106–10.CrossRef Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Eng J Med. 1995;333:1106–10.CrossRef
18.
go back to reference Louis E, Delooze D, Deprez P, et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol. 2002;14:279–84.PubMedCrossRef Louis E, Delooze D, Deprez P, et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol. 2002;14:279–84.PubMedCrossRef
19.
go back to reference Valle C, Broqlia F, Pistorio A, et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci. 1999;44:1848–52.PubMedCrossRef Valle C, Broqlia F, Pistorio A, et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci. 1999;44:1848–52.PubMedCrossRef
20.
go back to reference Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–9.PubMedCrossRef Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–9.PubMedCrossRef
21.
go back to reference Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther. 2004;19:375–6.PubMedCrossRef Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther. 2004;19:375–6.PubMedCrossRef
22.
go back to reference Pan GZ, Xu GM, Ke MY, et al. Epidemiological study of symptomatic gastro-esophageal reflux disease in China, Beijing and Shanghai. Chin J Dig Dis. 2000;1:2–8.CrossRef Pan GZ, Xu GM, Ke MY, et al. Epidemiological study of symptomatic gastro-esophageal reflux disease in China, Beijing and Shanghai. Chin J Dig Dis. 2000;1:2–8.CrossRef
23.
go back to reference Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population with particular sequence to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–22.PubMedCrossRef Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population with particular sequence to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–22.PubMedCrossRef
24.
go back to reference Khoshbaten M. Gastro-esophageal reflux disease in north-western Tabriz, Iran. Indian J Gastroenterol. 2003;22:138–9.PubMed Khoshbaten M. Gastro-esophageal reflux disease in north-western Tabriz, Iran. Indian J Gastroenterol. 2003;22:138–9.PubMed
25.
go back to reference Kang JY. Systematic review: geographical and ethnic differences in gastroesophageal reflux disease. Aliment Pharmacol Ther. 2004;20:705–17.PubMedCrossRef Kang JY. Systematic review: geographical and ethnic differences in gastroesophageal reflux disease. Aliment Pharmacol Ther. 2004;20:705–17.PubMedCrossRef
26.
go back to reference Ho KY, Kang JY, Seow A. Pattern of consultation and treatment for heartburn: findings from a Singapore community survey. Aliment Pharmacol Ther. 1999;11:1029–33.CrossRef Ho KY, Kang JY, Seow A. Pattern of consultation and treatment for heartburn: findings from a Singapore community survey. Aliment Pharmacol Ther. 1999;11:1029–33.CrossRef
27.
go back to reference Wang JH, Luo JY, Dong L, Gong J, Ting M. Epidemiology of gastro-oesophageal reflux disease: a general population-based study in Xian of Northwest China. World J Gastroenterol. 2004;10:1647–51.PubMed Wang JH, Luo JY, Dong L, Gong J, Ting M. Epidemiology of gastro-oesophageal reflux disease: a general population-based study in Xian of Northwest China. World J Gastroenterol. 2004;10:1647–51.PubMed
28.
go back to reference Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther. 2000;14:1589–94.PubMedCrossRef Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther. 2000;14:1589–94.PubMedCrossRef
29.
go back to reference Voutilainen M, Sippmen P, Meeklin JP, et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion. 2000;61:6–13.PubMedCrossRef Voutilainen M, Sippmen P, Meeklin JP, et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion. 2000;61:6–13.PubMedCrossRef
30.
go back to reference Lagergren J, Bergstrom R, Nyren O. No relation between body mass index and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000;47:26–9.PubMedCrossRef Lagergren J, Bergstrom R, Nyren O. No relation between body mass index and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000;47:26–9.PubMedCrossRef
31.
go back to reference Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807–11.PubMedCrossRef Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807–11.PubMedCrossRef
32.
go back to reference Rai RR, Sharma M. Prevalence and clinical spectrum of GERD in healthy population. Indian J Gastroenterol. 2004;23 suppl 2:A12. Rai RR, Sharma M. Prevalence and clinical spectrum of GERD in healthy population. Indian J Gastroenterol. 2004;23 suppl 2:A12.
33.
go back to reference Nelson M, Johnsen R, Ye W, Hveem K, Lagergren J. Life style related risk factors in the etiology of gastro-oesophageal reflux. Gut. 2004;13:1730–5.CrossRef Nelson M, Johnsen R, Ye W, Hveem K, Lagergren J. Life style related risk factors in the etiology of gastro-oesophageal reflux. Gut. 2004;13:1730–5.CrossRef
34.
go back to reference Kadakia SC, Kikendall JW, Maydmovitch C, et al. Effect of cigarette smoking on gastro-oesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol. 1995;90:1785–90.PubMed Kadakia SC, Kikendall JW, Maydmovitch C, et al. Effect of cigarette smoking on gastro-oesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol. 1995;90:1785–90.PubMed
35.
36.
go back to reference Kitzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastro-oesophageal reflux disease in a Medicaid population. Pharm Res. 2001;18:1367–72.CrossRef Kitzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastro-oesophageal reflux disease in a Medicaid population. Pharm Res. 2001;18:1367–72.CrossRef
37.
go back to reference Sontag SJ, Schnell TG, Miller TQ, et al. Prevalence of oesophagitis in asthmatics. Gut. 1992;33:872–6.PubMedCrossRef Sontag SJ, Schnell TG, Miller TQ, et al. Prevalence of oesophagitis in asthmatics. Gut. 1992;33:872–6.PubMedCrossRef
38.
go back to reference Kiligander TO, Laitinen JO. The prevalence of gastro-oesophageal reflux disease in adult asthmatics. Chest. 2004;126:1490–4.CrossRef Kiligander TO, Laitinen JO. The prevalence of gastro-oesophageal reflux disease in adult asthmatics. Chest. 2004;126:1490–4.CrossRef
39.
go back to reference Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–65.PubMedCrossRef Nishida T, Tsuji S, Tsujii M, et al. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19:258–65.PubMedCrossRef
Metadata
Title
Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in Northern India
Authors
Praveen Kumar Sharma
Vineet Ahuja
Kaushal Madan
Saurabh Gupta
Akshay Raizada
Mahesh Prakash Sharma
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 3/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-010-0065-5

Other articles of this Issue 3/2011

Indian Journal of Gastroenterology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.